Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie P Chin

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Cardiac Failure|December 8, 2014
Reply: To PMID 25307295Melanie P Chin, Colin J Meyer
Nitric Oxide : Biology and Chemistry|September 22, 2010
Prediction of nitric oxide concentrations in melanomasMelanie P Chin, William M Deen
Nitric Oxide : Biology and Chemistry|May 27, 2008
Prediction of nitric oxide concentrations in colonic crypts during inflammationMelanie P Chin, David B Schauer, William M Deen
Chemical Research in Toxicology|March 6, 2010
Nitric oxide, oxygen, and superoxide formation and consumption in macrophages and colonic epithelial cellsMelanie P Chin, David B Schauer, William M Deen
Cardiorenal Medicine|June 4, 2019
Effects of Bardoxolone Methyl on QT Interval in Healthy VolunteersMelanie P Chin, Shannon Rich, Angie Goldsberry, et al.
Cardiorenal Medicine|June 7, 2019
Effects of Bardoxolone Methyl on Magnesium in Patients with Type 2 Diabetes Mellitus and Chronic Kidney DiseaseDana V Rizk, Arnold L Silva, Pablo E Pergola, et al.
Journal of Cardiac Failure|October 14, 2014
Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methylMelanie P Chin, Danielle Wrolstad, George L Bakris, et al.
American Journal of Nephrology|June 7, 2014
Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methylMelanie P Chin, Scott A Reisman, George L Bakris, et al.
Clinical and Translational Science|August 30, 2020
Effects of Bardoxolone Methyl on Hepatic Enzymes in Patients with Type 2 Diabetes Mellitus and Stage 4 CKDJames H Lewis, Michel Jadoul, Geoffrey A Block, et al.
American Journal of Nephrology|February 7, 2018
Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes StudyMelanie P Chin, George L Bakris, Geoffrey A Block, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Cardiac Failure|December 8, 2014
Reply: To PMID 25307295Melanie P Chin, Colin J Meyer
Nitric Oxide : Biology and Chemistry|September 22, 2010
Prediction of nitric oxide concentrations in melanomasMelanie P Chin, William M Deen
Nitric Oxide : Biology and Chemistry|May 27, 2008
Prediction of nitric oxide concentrations in colonic crypts during inflammationMelanie P Chin, David B Schauer, William M Deen
Chemical Research in Toxicology|March 6, 2010
Nitric oxide, oxygen, and superoxide formation and consumption in macrophages and colonic epithelial cellsMelanie P Chin, David B Schauer, William M Deen
Cardiorenal Medicine|June 4, 2019
Effects of Bardoxolone Methyl on QT Interval in Healthy VolunteersMelanie P Chin, Shannon Rich, Angie Goldsberry, et al.
Cardiorenal Medicine|June 7, 2019
Effects of Bardoxolone Methyl on Magnesium in Patients with Type 2 Diabetes Mellitus and Chronic Kidney DiseaseDana V Rizk, Arnold L Silva, Pablo E Pergola, et al.
Journal of Cardiac Failure|October 14, 2014
Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methylMelanie P Chin, Danielle Wrolstad, George L Bakris, et al.
American Journal of Nephrology|June 7, 2014
Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methylMelanie P Chin, Scott A Reisman, George L Bakris, et al.
Clinical and Translational Science|August 30, 2020
Effects of Bardoxolone Methyl on Hepatic Enzymes in Patients with Type 2 Diabetes Mellitus and Stage 4 CKDJames H Lewis, Michel Jadoul, Geoffrey A Block, et al.
American Journal of Nephrology|February 7, 2018
Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes StudyMelanie P Chin, George L Bakris, Geoffrey A Block, et al.
Pageof 2